Role of Estrogen Receptors and Neurohypophyseal Gene Expression in Vasopressin Release in a Model of Dilutional Hyponatremia

稀释性低钠血症模型中雌激素受体和神经垂体基因表达在加压素释放中的作用

• 批准号: 10389144
• 负责人: DIANNA HUYEN-TRAM NGUYEN
• 金额: $ 3.32万
• 依托单位: UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-02-01 至 2025-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10389144
• 关键词: Acute; Address; Animal Model; Arginine; Blood Circulation; Body Fluids; Body Water; Brain-Derived Neurotrophic Factor; Cardiovascular system; Chronic Disease; Cirrhosis; Clinical; Congestive Heart Failure; Data; Development; ESR1 gene; Electrolyte Disorder; Estrogen Receptor beta; Estrogen Receptors; Female; Fluid Balance; Fostering; Fulvestrant; Functional disorder; GPER gene; Gene Expression; Goals; Heart failure; Hormones; Hospitals; Hyponatremia; Infusion procedures; Injury; Kidney; Knowledge; Lead; Ligation; Liquid substance; Literature; Liver Cirrhosis; Liver Failure; Modeling; Neuraxis; Neurons; Osmoregulation; Outcome; Oxytocin; Pathogenesis; Patients; Peripheral; Physiological; Posterior Pituitary Hormones; Prognosis; Proteins; Rattus; Regulation; Research; Resources; Risk Factors; Role; Sex Differences; Signal Transduction; Sodium; Spinal cord injury; Subarachnoid Hemorrhage; Surrogate Markers; System; Testing; Therapeutic; Trauma; United States; V2 Receptors; Vasopressins; Water; antagonist; bile duct; clinical practice; cost; defined contribution; dilutional hyponatremia; experimental study; insight; magnocellular; male; mortality; new therapeutic target; novel; novel therapeutic intervention; older patient; paraventricular nucleus; patient population; sex; sexual dimorphism; supraoptic nucleus; transcriptomics

Purpose: Hyponatremia is the most common electrolyte disorder and in 2006 the cost of treating hyponatremia in the US was estimated to be $1.6-$3.6 billion per year. Inappropriate vasopressin secretion is the major cause of dilutional hyponatremia associated with liver and heart failure. Our previous studies have also shown that, in male BDL rats, BDNF-TrkB signaling in the SON contributes sustained AVP and copeptin (a clinical surrogate for AVP 1-3) release, and hyponatremia 4. However, little is known about the role of sex differences in hyponatremia5. Our data show that female BDL rats do not develop hyponatremia or increased AVP release6. Instead female BDL rats show increased release of oxytocin6 . Our findings also suggest that the effects of BDL on neurohypophyseal hormones may be sexually dimorphic. Our central hypothesis is that ER in the hypothalamo-neurohypophyseal system (HNS) contribute, at least in part, to sex differences seen in the BDL model of dilutional hyponatremia. Our hypotheses will be tested with the following Specific Aims: Aim 1 will define the contributions of estrogen receptors in hypothalamo-neurohypophyseal neurons to sex differences in a model of dilutional hyponatremia Aim 2 will determine differences in SON gene expression that may contribute to underlying sex differences in AVP release in a model of dilutional hyponatremia Benefit: These experiments will address an existing gap in our understanding of neurophypophyseal function and the pathogenesis of hyponatremia. The findings of these experiments could potentially alter the way that inappropriate vasopressin release is studied and conceptualized clinically.

目的：低钠血症是最常见的电解质紊乱， 据估计，美国每年的低钠血症费用为16 - 36亿美元。加压素不当 分泌是与肝和心力衰竭相关的稀释性低钠血症的主要原因。我们 先前的研究也表明，在雄性BDL大鼠中，SON中的BDNF-TrkB信号传导 有助于持续的AVP和和肽素（AVP 1-3的临床替代物）释放，和 低钠血症4.然而，关于低钠血症中性别差异的作用知之甚少。我们 数据显示雌性BDL大鼠不发生低钠血症或增加AVP释放6。相反 雌性BDL大鼠表现出催产素6的释放增加。我们的研究结果还表明， BDL对神经垂体激素的影响可能具有性别差异。我们的核心假设是 下丘脑-神经垂体系统（HNS）中的ER至少部分地与性有关， 在稀释性低钠血症的BDL模型中观察到的差异。 我们的假设将通过以下具体目标进行检验： 目的1明确雌激素受体在下丘脑-神经垂体中的作用 稀释性低钠血症模型中神经元的性别差异 目的2将确定SON基因表达的差异，这可能有助于潜在的性别 稀释性低钠血症模型中AVP释放的差异 好处：这些实验将解决我们对人类基因组学的理解中存在的一个空白。 神经垂体功能和低钠血症的发病机制。之结果 实验可能潜在地改变不适当的加压素释放的研究方式， 临床概念化。